Cytoskeletal determinants of goal-directed decision-making

目标导向决策的细胞骨架决定因素

基本信息

  • 批准号:
    8847571
  • 负责人:
  • 金额:
    $ 4.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-02 至 2017-04-01
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cocaine dependence is a significant ongoing public health concern, in part because there is no effective pharmacological treatment, and the likelihood of relapse after recovery remains high. Cocaine is known to cause long-term, persistent changes in the prefrontal cortex, a brain region responsible for decision-making strategies and reward valuation. These changes occur even at the level of dendritic spines, the primary communication points between neurons. Cocaine-induced alteration of prefrontal cortical dendritic spines may thus be a contributing factor to cocaine addiction and relapse. Both humans and rodents can learn to associate specific actions with their outcomes. These actions are considered 'goal-directed,' meaning their performance is sensitive to changes in the relationship between the action and its outcome. With repetition or exposure to drugs of abuse such as cocaine, goal-directed responding can shift from being outcome-sensitive to being automatic, or 'habitual', which is defined by insensitivity to changes in the action-outcome relationship. Restoring goal-directed decision-making after habit formation in experimental models has proven particularly challenging, but it is a critical research imperative because although the development of habits can serve adaptive purposes, habitual behaviors that occur at the expense of goal-directed decision-making are thought to play a role in addiction etiology. This proposal aims to identify the cellular mechanisms of goal-directed behavior and to restore goal-directed decision-making in mice that have developed habits due to cocaine exposure. I will focus on ROCK, a key regulator of the actin cytoskeleton that controls contractile-dependent remodeling of dendritic spines. I have shown that the ROCK inhibitor HA-1077 restores goal-directed decision-making in extensively trained mice that otherwise engage in stimulus-response habits. By contrast, cocaine exposure induces habits. These findings raise the provocative possibility that targeting cytoskeletal regulators such as ROCK may be useful in the treatment of cocaine dependence and prevention of relapse. I propose to: 1) Reverse cocaine-induced habits, as well as block habitual responding for cocaine, using HA-1077. 2) Use in vivo multiphoton microscopy to quantify, in real time, the morphological response of prefrontal cortical dendritic spines to cocaine exposure. I will next isolate the effects of HA-1077 intervention with the expectation that HA-1077 will reverse the structural consequences of cocaine exposure. Whether cocaine-induced alterations of prefrontal cortical dendritic spines are a contributing factor to addiction etiology represents a lively debate in the field, especially since few research groups are equipped with the tools to both model cocaine-induced maladaptive decision-making and to isolate cytostructural modifications in tandem. I will harness these tools to comprehensively address this gap in current knowledge.
描述(由申请人提供):可卡因依赖是一个重要的持续公共卫生问题,部分原因是没有有效的药物治疗,恢复后复发的可能性仍然很高。众所周知,皮质醇会导致前额叶皮层的长期持续变化,前额叶皮层是负责决策策略和奖励评估的大脑区域。这些变化甚至发生在树突棘的水平上,树突棘是神经元之间的主要交流点。可卡因引起的前额叶皮质树突棘的改变可能是可卡因成瘾和复发的一个因素。 人类和啮齿动物都能学会将特定的行为与结果联系起来。这些行动被认为是“目标导向的”,这意味着它们的表现对行动及其结果之间关系的变化很敏感。随着重复或暴露于滥用药物(如可卡因),目标导向反应可以从结果敏感转变为自动或“习惯性”,其定义为对行为-结果关系的变化不敏感。在实验模型中,在习惯形成后恢复目标导向的决策已被证明特别具有挑战性,但这是一个关键的研究任务,因为尽管习惯的发展可以达到适应性目的,但以目标导向的决策为代价发生的习惯行为被认为在成瘾病因学中发挥作用。该提案旨在确定目标导向行为的细胞机制,并恢复因可卡因暴露而养成习惯的小鼠的目标导向决策。 我将集中在ROCK,肌动蛋白细胞骨架的关键调节器,控制树突棘的收缩依赖性重塑。我已经证明,ROCK抑制剂HA-1077恢复了经过广泛训练的小鼠的目标导向决策,否则这些小鼠会陷入刺激-反应习惯。相比之下,可卡因暴露会诱发习惯。这些发现提出了一种挑衅性的可能性,即靶向细胞骨架调节剂如ROCK可能有助于治疗可卡因依赖和预防复发。我建议:1)使用HA-1077逆转可卡因诱导的习惯,以及阻断可卡因的习惯性反应。 2)在体内使用多光子显微镜定量,在真实的时间,前额叶皮质树突棘可卡因暴露的形态反应。接下来,我将分离HA-1077干预的影响,期望HA-1077将逆转可卡因暴露的结构性后果。 可卡因引起的前额叶皮质树突棘的改变是否是成瘾病因学的一个促成因素,在该领域引起了激烈的争论,特别是 因为很少有研究小组配备了既能模拟可卡因诱导的适应不良决策又能分离串联的细胞结构修饰的工具。我将利用这些工具来全面解决当前知识中的这一差距。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew Swanson其他文献

Andrew Swanson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew Swanson', 18)}}的其他基金

Cytoskeletal determinants of goal-directed decision-making
目标导向决策的细胞骨架决定因素
  • 批准号:
    8718247
  • 财政年份:
    2014
  • 资助金额:
    $ 4.31万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了